Found: 15
Select item for more details and to access through your institution.
'Tumor immunology meets oncology (TIMO) VI' from 7th to 8th of May 2010 in Halle, Germany.
- Published in:
- 2011
- By:
- Publication type:
- Report
CDR2 antigen and Yo antibodies.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 283, doi. 10.1007/s00262-010-0943-9
- By:
- Publication type:
- Article
CD8 Co-receptor promotes susceptibility of CD8 T cells to transforming growth factor-β (TGF-β)-mediated suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 291, doi. 10.1007/s00262-010-0962-6
- By:
- Publication type:
- Article
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 217, doi. 10.1007/s00262-010-0931-0
- By:
- Publication type:
- Article
Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 227, doi. 10.1007/s00262-010-0933-y
- By:
- Publication type:
- Article
Migration and immunological reaction after the administration of αGalCer-pulsed antigen-presenting cells into the submucosa of patients with head and neck cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 207, doi. 10.1007/s00262-010-0932-z
- By:
- Publication type:
- Article
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 197, doi. 10.1007/s00262-010-0927-9
- By:
- Publication type:
- Article
Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 273, doi. 10.1007/s00262-010-0941-y
- By:
- Publication type:
- Article
Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 153, doi. 10.1007/s00262-010-0946-6
- By:
- Publication type:
- Article
IL-21-treated naive CD45RA CD8 T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 235, doi. 10.1007/s00262-010-0936-8
- By:
- Publication type:
- Article
Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 249, doi. 10.1007/s00262-010-0942-x
- By:
- Publication type:
- Article
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 261, doi. 10.1007/s00262-010-0935-9
- By:
- Publication type:
- Article
Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 161, doi. 10.1007/s00262-010-0929-7
- By:
- Publication type:
- Article
Primed tumor-reactive multifunctional CD62L human CD8 T cells for immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 173, doi. 10.1007/s00262-010-0928-8
- By:
- Publication type:
- Article
Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 187, doi. 10.1007/s00262-010-0934-x
- By:
- Publication type:
- Article